검색결과 : 300건
| No. | Article |
|---|---|
| 1 |
Synthesis of Multifunctional Organic Nanoparticles Combining Photodynamic Therapy and Chemotherapeutic Drug Release Sozmen F, Kucukoflaz M, Ergul M, Inan ZDS, Bozkurt Y, Taydas D Macromolecular Research, 30(1), 61, 2022 |
| 2 |
Targeting RNF8 effectively reverses cisplatin and doxorubicin resistance in endometrial cancer Yang B, Ke W, Wan YC, Li T Biochemical and Biophysical Research Communications, 545, 89, 2021 |
| 3 |
Interactions of anticancer drugs doxorubicin and idarubicin with lipid monolayers: New insight into the composition, structure and morphology Matyszewska D, Nazaruk E, Campbell RA Journal of Colloid and Interface Science, 581, 403, 2021 |
| 4 |
In vitro intracellular studies of pH and thermo-triggered doxorubicin conjugated magnetic SBA-15 mesoporous nanocarriers for anticancer activity against hepatocellular carcinoma Mdlovu NV, Lin KS, Weng MT, Hsieh CC, Lin YS, Espinoza MJC Journal of Industrial and Engineering Chemistry, 102, 1, 2021 |
| 5 |
In vitro study of doxorubicin-loaded thermo- and pH-tunable carriers for targeted drug delivery to liver cancer cells Kunene SC, Lin KS, Weng MT, Espinoza MJC, Wu CM Journal of Industrial and Engineering Chemistry, 104, 93, 2021 |
| 6 |
Doxorubicin delivery systems based on doped CaCO3 cores and polyanion drug conjugates Sudareva N, Suvorova O, Saprykina N, Vlasova H, Vilesov A Journal of Microencapsulation, 38(3), 164, 2021 |
| 7 |
Green synthesis of gold nanoparticles coated doxorubicin liposomes using procyanidins for light-controlled drug release Hou KX, Bao ML, Xin C, Wang L, Zhang H, Zhao HT, Wang ZY Advanced Powder Technology, 31(8), 3640, 2020 |
| 8 |
Doxorubicin inhibits PD-L1 expression by enhancing UP-mediated decay of PD-L1 mRNA in cancer cells Kim DJ, Jang JH, Ham SY, Choi SH, Park SS, Jeong SY, Kim BC, Jeon DY, Lee BJ, Ko BK, Park JW, Cho WJ Biochemical and Biophysical Research Communications, 522(2), 402, 2020 |
| 9 |
MicroRNA-22 inhibition prevents doxorubicin-induced cardiotoxicity via upregulating SIRT1 Xu C, Liu CH, Zhang DL Biochemical and Biophysical Research Communications, 521(2), 485, 2020 |
| 10 |
PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma Ma WL, Yang L, Liu H, Chen P, Ren H, Ren P Biochemical and Biophysical Research Communications, 521(1), 204, 2020 |